Ani Pharmaceuticals ANIP
NASDAQ ANIP
$70.70 +0.47 (+0.67%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ani Pharmaceuticals (ANIP) EBT Margin (QoQ) (2011 - 2026)

Analysis

Ani Pharmaceuticals (ANIP) EBT Margin (QoQ) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -299.00
Mar 31, 2026 420.00
Dec 31, 2025 -210.00
Sep 30, 2025 986.00
Jun 30, 2025 -516.00
Mar 31, 2025 1,736.00
Dec 31, 2024 1,401.00
Sep 30, 2024 -1,958.00
Jun 30, 2024 -2,009.00
Mar 31, 2024 1,772.00
Dec 31, 2023 -801.00
Sep 30, 2023 423.00
Jun 30, 2023 244.00
Mar 31, 2023 814.00
Dec 31, 2022 850.00
Sep 30, 2022 1,090.00
Jun 30, 2022 1,469.00
Mar 31, 2022 1,047.00
Dec 31, 2021 -3,694.00
Sep 30, 2021 2,373.00